CoChat

Insulin‐like growth factor‐1 activates Akt and Jun N‐terminal kinases (JNKs) in promoting the survival of T lymphocytes

Walsh, Patrick T., Smith, Loraine M., O'Connor, Rosemary · 2002 · Immunology
Cited by 68

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Summary: Insulin‐like growth factor 1 receptor (IGF‐1R) expression is augmented on T cells upon ligation of CD28, and this promotes IGF‐1‐mediated protection from Fas‐induced cell death for up to 6 days. To determine the mechanism of action of IGF‐1R in T‐cell expansion, we investigated the signalling pathways activated by IGF‐1 in T cells and in Jurkat cells. We found that IGF‐1 transiently induces Akt, jun N‐terminal kinases (JNK), and c‐Jun phosphorylation in activated T cells, with JNK and c‐Jun phosphorylation occurring faster than Akt phosphorylation. To mimic IGF‐1R expression levels in CD28‐stimulated Jurkat cells these cells were stably transfected to over‐express the IGF‐1R. Jurkat/IGF‐1R cells exhibited enhanced constitutive Akt phosphorylation compared with mock‐transfected controls, but IGF‐1 induced transient phosphorylation of MKK4, JNKs, and c‐Jun. Inhibition of PI‐3 kinase activity and Akt phosphorylation with LY294002 totally suppressed IGF‐1‐mediated protection from Fas killing in activated T cells, but only partially suppressed IGF‐1‐mediated protection in Jurkat/IGF‐1R cells. However, either dicumarol in T cells or a dominant negative JNK1 (APF) in Jurkat/IGF‐1R cells greatly suppressed IGF‐1‐mediated protection from Fas killing. Together, these data demonstrate that IGF‐1‐mediated activation of JNKs and PI‐3 kinase contributes to normal T‐cell survival, whereas the JNK pathway may be more important in Jurkat leukaemia cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2567.2002.01525.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 68

Metadata

Authors
Walsh, P. T., Smith, L. M., & O'Connor, R.
Venue
Immunology
Publisher
Wiley
Published
2002-12
Volume
107
Issue
4
Pages
461-471
ISSN
  • 0019-2805 (ISSN-L)
  • 1365-2567
OpenAlex
W2028062775
Cited by
68
References
6
FWCI
3.44
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insulin‐like growth factor‐1 activates Akt and Jun N‐terminal kinases (JNKs) in promoting the survival of T lymphocytes. https://app.cochat.ai/papers/10.1046/j.1365-2567.2002.01525.x
The paper
Walsh, P. T., Smith, L. M., & O'Connor, R. (2002). Insulin‐like growth factor‐1 activates Akt and Jun N‐terminal kinases (JNKs) in promoting the survival of T lymphocytes. Immunology. https://doi.org/10.1046/j.1365-2567.2002.01525.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.